Jordan Park Group LLC Buys 170 Shares of Danaher Co. (NYSE:DHR)

Jordan Park Group LLC lifted its stake in Danaher Co. (NYSE:DHR) by 17.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,129 shares of the conglomerate’s stock after acquiring an additional 170 shares during the period. Jordan Park Group LLC’s holdings in Danaher were worth $259,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the fourth quarter valued at $31,000. Teachers Insurance & Annuity Association of America bought a new stake in Danaher in the third quarter valued at $39,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in Danaher in the third quarter valued at $40,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 10.90% of the company’s stock.

Danaher Price Performance

Danaher stock opened at $205.23 on Thursday. The business’s 50-day simple moving average is $227.74 and its 200 day simple moving average is $247.80. The stock has a market cap of $148.24 billion, a price-to-earnings ratio of 38.87, a P/E/G ratio of 2.63 and a beta of 0.83. Danaher Co. has a 12-month low of $196.80 and a 12-month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 EPS. As a group, research analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Analyst Ratings Changes

A number of brokerages have weighed in on DHR. Jefferies Financial Group lowered their price target on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Scotiabank assumed coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target on the stock. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, TD Cowen increased their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.